References
- Blum K A, Hamadani M, Phillips G S, et al. Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma. Leuk Lymphoma 2009; 50: 349–356
- Nabhan C, Fried W, Galvez A, Venugopal P, Gozun P, Bitran J. Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL). J Clin Oncol 2008; 26, Abstract 8564 (pp. 470)